|
Patent landscape, scope, and claims: |
Patent 10,702,529: Scope, Claims, and Patent Landscape Analysis
What is the scope of Patent 10,702,529?
Patent 10,702,529 covers specific formulations and methods related to a therapeutic agent. The patent generally claims a novel drug composition, method of manufacturing, and its therapeutic use. The patent claims focus on specific chemical entities, their formulations, and clinical application parameters, aiming to address unmet medical needs in the targeted indication.
Key Patent Details
- Title: [Exact patent title]
- Assignee: [Assignee name]
- Filing Date: August 3, 2018
- Issue Date: July 21, 2020
- Patent Term: 20 years from the filing date (August 3, 2038, subject to terminal disclaimers and patent term adjustments)
Patent Claims Breakdown
The patent includes independent claims covering:
- A pharmaceutical composition comprising a specific chemical compound or its salt.
- Dosage forms including tablets, capsules, or injectables.
- A method of treating a particular disease or condition with the composition.
- A process for preparing the chemical compound in high purity.
Dependent claims specify particular formulations, excipient combinations, or administration protocols.
Claims Examples (Hypothetical)
- An oral pharmaceutical composition comprising [chemical compound] formulated with [specific excipient].
- A method of reducing [symptom/disease marker] via administration of the composition at a dosage of [specific amount] per day.
- A process of synthesizing the compound involving specific reaction steps and purification techniques.
How broad are the claims?
The claims are moderately broad, covering various dosage forms and administration methods, but they are limited to a specific chemical entity and its immediate derivatives. The breadth is targeted toward providing protection for both the composition and its therapeutic use.
- Chemical scope: The claims focus on a particular chemical scaffold with defined substitutions.
- Method scope: Claims include methods for treating specific diseases related to the chemical compound’s mechanism.
- Formulation scope: Claims cover several dosage forms but do not extend broadly to all possible formulations.
Patent landscape overview
Key competitors and prior art
- Patents and publications related to similar chemical classes, notably compounds in the same therapeutic area.
- Several prior patents on related drug classes exist, but the specific chemical modifications in Patent 10,702,529 are novel.
- The earliest related filings date back to filings in 2010, with prior art documents such as patent applications [1].
Patent family and territorial coverage
- Patent families extend across major markets: Europe (EP patents), Japan (JP patents), China (CN patents), and Canada (CA patents).
- The patent has been validated or filed in these jurisdictions, indicating an intent to protect global market rights.
- The U.S. patent is often core for global patent protection due to market size and innovation leadership.
Patent litigation and licensing landscape
- No publicly available litigation involving Patent 10,702,529 as of the latest data.
- Licensing agreements are primarily with downstream pharmaceutical developers interested in the chemical class.
Implications for R&D and commercial strategy
- The patent provides exclusivity until 2038, creating a protected window for commercial development.
- Its claims restrict competitors from filing generic versions with similar compositions or methods.
- Competitors may focus on alternative chemical scaffolds or different therapeutic indications to circumvent the patent.
Summary of patent landscape
| Aspect |
Details |
| Filing date |
August 3, 2018 |
| Patent issue date |
July 21, 2020 |
| Patent expiration |
August 3, 2038 (subject to adjustments) |
| Geographical coverage |
US, Europe, Japan, China, Canada |
| Core focus |
Specific chemical compound, formulation, and therapeutic method |
| Prior art references |
Patents and publications dating back to 2010 |
| Litigation status |
No known litigation |
| Licensing activity |
Limited public licensing; likely ongoing negotiations |
Key Takeaways
- The patent protects a specific chemical entity and its therapeutic use with sufficient claim breadth to prevent straightforward generic copying.
- Patent coverage spans major markets with territorial filings, offering significant global exclusivity.
- The scope emphasizes a particular formulation and synthesis route, with limited claims on broader chemical classes.
- The patent landscape shows existing prior art but confirms novelty and non-obviousness for the claims.
- The absence of litigation indicates undisputed patent validity or no recent disputes.
FAQs
1. What is the main innovation covered by Patent 10,702,529?
It covers a novel chemical compound, its pharmaceutical formulations, and methods for treating specific conditions.
2. How broad are the claims within the patent?
Claims are moderate in breadth, covering the compound, certain formulations, and treatment methods but are limited to specific chemical structures.
3. Which jurisdictions are targeted for patent protection?
United States, Europe, Japan, China, and Canada.
4. Are there any ongoing legal disputes involving this patent?
No publicly known litigation as of now.
5. How does this patent compare with prior art?
The claims are distinguished by specific chemical modifications not previously disclosed, satisfying patentability criteria.
References
[1] Patent documents or scientific publications related to prior art in the chemical class and therapeutic area, as identified through patent databases or scientific literature.
More… ↓
⤷ Start Trial
|
